Balu4u
Shareholder alert
https://www.finanzen.net/nachricht/aktien/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-orphazyme-a-s-of-class-action-lawsuit-and-upcoming-deadline-orph-10484143
Balu4u
Positive data of arimoclomol
https://www.globenewswire.com/news-release/2021/08/23/2284587/0/en/Orphazyme-announces-publication-of-results-from-its-Phase-2-3-trial-of-arimoclomol-in-Niemann-Pick-disease-type-C-in-the-Journal-of-Inherited-Metabolic-Disease.html
Balu4u
Here's why ORPH stock is on the move
https://investorplace.com/2021/08/dear-orph-stock-fans-mark-your-calendars-for-august-31/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+InvestorPlace+%28InvestorPlace%29